Gary H. Lyman, MD, MPH
Advertisement
Articles by Gary H. Lyman, MD, MPH
Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
Advertisement
Latest Updated Articles
- Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
Published: April 16th 2015 | Updated:
- Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Published: February 13th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
2
USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar
3
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
4
β-Blockers Show No Added Benefit After MI With Preserved LVEF
5
